Thermo Fisher price target raised to $680 from $615 at Stifel

Stifel raised the firm’s price target on Thermo Fisher to $680 from $615 and keeps a Buy rating on the shares. The company’s investor day commentary on 2025 was “essentially nil,” as expected, but the long-term outlook calling for 7-9% growth was formally reiterated, the analyst tells investors. While there was no real change on the tone on China, the firm found commentary on the biopharma market to be constructive and overall thought the day was “helpful” and continues to favor Thermo Fisher within its group, citing execution, an “approachable” valuation and the above-average share gain opportunities.